07:25 AM EDT, 06/04/2024 (MT Newswires) -- Amphastar Pharmaceuticals ( AMPH ) said Tuesday that its board approved a $50 million increase to the company's share buyback program.
The repurchase program is effective over an indefinite period, Amphastar said.